Unitree Q3 Revenue Rises 70 Percent as Model Spend Jumps

Unitree Robotics, the Hangzhou humanoid and quadruped maker listed on Shanghai's STAR Market as 688836, posted third-quarter revenue of RMB 665.0 million (approximately US$93 million), up 69.93 percent from a year earlier. Profit did not follow. Net profit attributable to shareholders fell 17.37 percent to RMB 112.7 million (approximately US$16 million).

The quarter is the first full public earnings print since Unitree completed its initial listing. Earlier RobotAIGeek coverage tracked the IPO path and first-quarter growth. This filing adds a different fact: sales are still expanding, but the cost of training embodied models is now large enough to pull quarterly profit down.

Revenue growth without a matching profit line

The unaudited report, filed with the Shanghai Stock Exchange disclosure system on 29 October 2026 and dated 28 October, puts nine-month revenue at RMB 1.817 billion (approximately US$255 million), up 55.71 percent. Nine-month net profit rose 270.54 percent to RMB 386.7 million (approximately US$54 million). That jump is not a clean operating beat. The company said a large one-time share-payment expense in the prior year inflated the comparison.

Strip those items out and the picture is flatter. Nine-month profit excluding non-recurring gains fell 18.78 percent to RMB 349.0 million (approximately US$49 million). In the third quarter alone, profit excluding non-recurring items fell 17.42 percent to RMB 105.0 million (approximately US$15 million). Basic earnings per share for the quarter were RMB 0.30, down 20.32 percent.

Cash from operations also weakened. For the first nine months, net operating cash flow was RMB 193.7 million (approximately US$27 million), down 54.69 percent. Unitree tied the drop to higher cash paid for goods, labor, sales, and research as revenue grew. Total assets jumped 216.52 percent to RMB 10.16 billion (approximately US$1.43 billion), which the company attributed mainly to IPO proceeds sitting in cash.

Where the money is going

Research and development is the line that explains the profit gap. Third-quarter R&D spending was RMB 127.0 million (approximately US$18 million), up 249.58 percent, equal to 19.10 percent of quarterly revenue. That ratio rose 9.82 percentage points from a year earlier. Over nine months, R&D reached RMB 262.9 million (approximately US$37 million), up 191.48 percent and equal to 14.47 percent of revenue.

Unitree's own explanation is specific. It said the increase came from continued spending on embodied intelligence, especially embodied large-model research and computing power, plus a larger research team and new product work. It did not publish a product-level revenue split, a shipment count, or a humanoid order backlog in this report. Those figures are not in the filing, so they are not assumed here.

The company described the revenue gain more generally: continued product innovation, a broader product matrix, and better fit with customer demand. Weighted average return on net assets for the quarter was 2.30 percent, down 3.47 percentage points.

What buyers should read into a listed humanoid maker

A listed humanoid company can now be scored the way industrial-robot makers have been scored for years: growth against cash, and research intensity against margin. Unitree cleared that test on sales and failed it on quarterly profit and operating cash. The filing says the research bill is intentional. It does not say when model spending stops outrunning incremental profit.

Investors who treated the STAR Market listing as proof that humanoid demand had already matured now have a harder number. Revenue can rise 70 percent in a quarter and still leave profit lower if computing and headcount scale faster than shipments. That is a capital-cycle story, not a demand-collapse story. It is also not evidence that humanoid deployments have reached factory scale. The report does not make that claim.

The next useful print is the annual report, which should show whether fourth-quarter sales cover a research ratio near 19 percent. Until then, the verified signal is narrow and clear. Unitree is growing, funding that growth with IPO cash, and spending heavily on embodied models. Profit in the latest quarter did not keep up.

This analysis synthesizes the company's unaudited quarterly filing and its stated reasons for the changes in revenue, profit, cash flow, and research spending.

This article is for informational purposes only and does not constitute investment, legal, or purchasing advice. Figures are drawn from company filings and public statements available at publication and may be revised.